In this study, by employing adrenocortical carcinoma H295R cells [18–22], we examined the interaction between Ang II and insulin/IGF-1 in ERK and AKT signaling pathways and expression of steroidogenic enzymes in the cells. Here, IGF1 is linked to adrenal cortex carcinoma.